Publications. Poggenborg RP. Assessment of inflammation and structural damage in psoriatic arthritis by modern MRI and CT methods. 2013.

Publications 2013 Poggenborg RP, Wiell C, Bøyesen P, Boonen A, Bird P, Pedersen SJ et al. No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial. Rheumatology (Oxford, England). 2013 dec 24. Tilgængelig fra: 10.1093/rheumatology/ket426 Putrik P, Ramiro S, Kvien TK, Sokka T, Uhlig T, Boonen A et al. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?. Annals of the Rheumatic Diseases. 2013 dec 20. Tilgængelig fra: 10.1136/annrheumdis-2013-203819 Poggenborg R, Bird P, Boonen A, Wiell C, Pedersen SJ, Sørensen IJ et al. Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: a high-resolution computed tomography and radiography follow-up study during adalimumab therapy. Scandinavian Journal of Rheumatology. 2013 dec 19. Tilgængelig fra: 10.3109/03009742.2013.835865 Poggenborg RP. Assessment of inflammation and structural damage in psoriatic arthritis by modern MRI and CT methods. 2013. Pedersen SJ, Zhao Z, Lambert RG, Wichuk S, Østergaard M, Weber U et al. The FAt Spondyloarthritis Spine Score (FASSS): development and validation of a new scoring method for the evaluation of fat lesions in the spine of patients with axial spondyloarthritis. Arthritis Research & Therapy. 2013 dec 16;15(6):R216. Tilgængelig fra: 10.1186/ar4411 Baker JF, Conaghan PG, Smolen JS, Aletaha D, Shults J, Emery P et al. Development and validation of modified disease activity scores in rheumatoid arthritis: Superior correlation with MRI synovitis and X-ray progression. Arthritis & Rheumatism. 2013 dec 10. Tilgængelig fra: 10.1002/art.38304 Ammitzbøll CG, Thiel S, Jensenius JC, Ellingsen TJ, Hørslev-Petersen K, Hetland ML et al. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis. Arthritis & Rheumatism. 2013 dec;65(12):3045-50. Tilgængelig fra: 10.1002/art.38179 Bakewell CJ, Olivieri I, Aydin SZ, Dejaco C, Ikeda K, Gutierrez M et al. Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives. Journal of Rheumatology. 2013 dec;40(12):1951-7. Tilgængelig fra: 10.3899/jrheum.130643

Axelsen MB, Ejbjerg BJ, Hetland ML, Skjødt H, Majgaard O, Lauridsen UB et al. Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging. Scandinavian Journal of Rheumatology. 2013 nov 6. Tilgængelig fra: 10.3109/03009742.2013.824022 Greisen SR, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Hvid M et al. Increased soluble programmed death-1 (spd-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2013 nov 1. Tilgængelig fra: 10.3109/03009742.2013.823517 Terslev L, Naredo E, Iagnocco A, Balint PV, Wakefield RJ, Aegerter P et al. Defining enthesitis in spondyloarthritis by ultrasound: Results of a Delphi process and of a reliability reading exercise. Arthritis Care & Research. 2013 okt 21. Tilgængelig fra: 10.1002/acr.22191 Terslev L, Hammer HB, Torp-Pedersen S, Szkudlarek M, Iagnocco A, D'Agostino MA et al. EFSUMB Minimum Training Requirements for Rheumatologists Performing Musculoskeletal Ultrasound. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2013 okt;34(5):475-477. Tilgængelig fra: 10.1055/s-0033-1335143 American College of Rheumatology Rheumatoid Arthritis Clinical Trials Task Force Imaging Group and Outcome Measures in Rheumatology Magnetic Resonance Imaging Inflammatory Arthritis Working Group, Østergaard M. Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis. Arthritis & Rheumatism. 2013 okt;65(10):2513-23. Tilgængelig fra: 10.1002/art.38083 Linde L, Sørensen J, Østergaard M, Hetland ML. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice. Journal of Rheumatology. 2013 sep;40(9):1479-86. Tilgængelig fra: 10.3899/jrheum.121387 Bruyn GAW, Hanova P, Iagnocco A, d'agostino M-A, Möller I, Terslev L et al. Ultrasound definition of tendon damage in patients with rheumatoid arthritis. Results of a OMERACT consensus-based ultrasound score focussing on the diagnostic reliability. Annals of the Rheumatic Diseases. 2013 aug 22. Tilgængelig fra: 10.1136/annrheumdis-2013-203596 Naredo E, D'Agostino MA, Wakefield RJ, Möller I, Balint PV, Filippucci E et al. Reliability of a consensusbased ultrasound score for tenosynovitis in rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013 aug;72(8):1328-34. Tilgængelig fra: 10.1136/annrheumdis-2012-202092

Baker JF, Østergaard M, Emery P, Hsia EC, Lu J, Baker DG et al. Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial. Annals of the Rheumatic Diseases. 2013 jul 31. Tilgængelig fra: 10.1136/annrheumdis-2013-203444 Krintel SB, Grunert VP, Hetland ML, Johansen JS, Rothfuss M, Palermo G et al. The frequency of antiinfliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure. Rheumatology (Oxford, England). 2013 jul;52(7):1245-53. Tilgængelig fra: 10.1093/rheumatology/ket017 Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D'Agostino M-A et al. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2013 jun;72(6):804-14. Tilgængelig fra: 10.1136/annrheumdis-2012-203158 Peterfy C, Østergaard M, Conaghan PG. MRI comes of age in RA clinical trials. Annals of the Rheumatic Diseases. 2013 jun;72(6):794-6. Tilgængelig fra: 10.1136/annrheumdis-2012-202696 Jensen TW, Hansen MS, Hørslev-Petersen K, Hyldstrup L, Abrahamsen B, Langdahl BL et al. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intraarticular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial. Annals of the Rheumatic Diseases. 2013 maj 9;0:1-7. Tilgængelig fra: 10.1136/annrheumdis-2012-203171 Dougados M, Devauchelle-Pensec V, Ferlet JF, Jousse-Joulin S, D'Agostino M-A, Backhaus M et al. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound. Annals of the Rheumatic Diseases. 2013 maj;72(5):665-71. Tilgængelig fra: 10.1136/annrheumdis-2012-201469 Glintborg B, Ostergaard M, Krogh NS, Andersen MD, Tarp U, Loft AG et al. Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry. Excerpta Medica. Section 31: Arthritis and Rheumatism. 2013 maj;65(5):1213-23. Tilgængelig fra: 10.1002/art.37876 Axelsen MB, Poggenborg RP, Stoltenberg M, Kubassova O, Boesen M, Hørslev-Petersen K et al. Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 2013;42(2):115-22. Tilgængelig fra: 10.3109/03009742.2012.723745

Conaghan PG, Østergaard M, D'Agostino MA, Gaylis N, Arnold W, Olech E et al. Proceedings from the 5th annual international society for musculoskeletal imaging in rheumatology annual conference. Seminars in Arthritis and Rheumatism. 2013;42(4):433-46. Tilgængelig fra: 10.1016/j.semarthrit.2012.10.003 Dreyer L, Mellemkjær L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T et al. Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry. Annals of the Rheumatic Diseases. 2013;72(1):79-82. Tilgængelig fra: 10.1136/annrheumdis-2012-201969 Døhn UM, Terslev L, Szkudlarek M, Hansen MS, Hetland ML, Hansen A et al. Detection, scoring and volume assessment of bone erosions by ultrasonography in rheumatoid arthritis: comparison with CT. Annals of the Rheumatic Diseases. 2013;72(4):530-4. Tilgængelig fra: 10.1136/annrheumdis-2011-201114 Glintborg B, Østergaard M, Krogh NS, Tarp U, Manilo N, Loft AGR et al. Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases. 2013;72:1149-1155. Tilgængelig fra: 10.1136/annrheumdis-2012-201933 Jensen P, Wiell C, Milting K, Poggenborg RP, Østergaard M, Johansen JS et al. Plasma YKL-40: a potential biomarker for psoriatic arthritis?. European Academy of Dermatology and Venereology. Journal. 2013;27:815-819. Tilgængelig fra: 10.1111/j.1468-3083.2012.04570.x Poggenborg RP. Nye fremskridt indenfor billeddiagnostik. BestPractice. 2013;22(Suppl. 6):12-3. Smolen JS, Schoels MM, Nishimoto N, Breedveld FC, Burmester GR, Dougados M et al. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Annals of the Rheumatic Diseases. 2013;72:482-92. Tilgængelig fra: 10.1136/annrheumdis-2012-202469 Terslev L. Har ultralydsundersøgelse plads i treat-to-target ved perifer artrit?. BestPractice. 2013;(21). Weber U, Zubler V, Pedersen SJ, Rufibach K, Lambert RGW, Chan SM et al. Development and validation of an MRI reference criterion for defining a positive SIJ MRI in spondyloarthritis. Arthritis Care & Research. 2013;65(6):977-985. Tilgængelig fra: 10.1002/acr.21893 Wiell C, Szkudlarek M, Hasselquist M, Møller JM, Nørregaard J, Terslev L et al. Power Doppler ultrasonography of painful Achilles tendons and entheses in patients with and without spondyloarthropathy-a comparison with clinical examination and contrast-enhanced MRI. Clinical Rheumatology. 2013;32(3):301-8. Tilgængelig fra: 10.1007/s10067-012-2111-4

Ørnbjerg LM, Østergaard M, Bøyesen P, Krogh NS, Thormann A, Tarp U et al. Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry. Annals of the Rheumatic Diseases. 2013;72(1):57-63. Tilgængelig fra: 10.1136/annrheumdis-2012-201319 Slot O. Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout. Annals of the Rheumatic Diseases. 2013;72(3):457. Tilgængelig fra: 10.1136/annrheumdis-2012-202023 Jensen DV, Hetland ML. DANBIO Årsrapport 2012. Eget Forlag, 2013. Krintel SB. Potential biomarkers of treatment response and adverse drug reactions to TNFα inhibitor therapy in patients with rheumatoid arthritis. 2013. Cobb JE, Plant D, Flynn E, Tadjeddine M, Dieudé P, Cornélis F et al Identification of the tyrosine-protein phosphatase non-receptor type 2 as a rheumatoid arthritis susceptibility locus in europeans [Online] 2013 [Citeret 2013 jan 01] Tilgængelig fra: 10.1371/journal.pone.0066456 2012 Whittle SL, Colebatch AN, Buchbinder R, Edwards CJ, Adams K, Englbrecht M et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford, England). 2012 mar 24;1416-25. Tilgængelig fra: doi:10.1093/rheumatology/kes032 Axelsen MB, Stoltenberg M, Poggenborg RP, Kubassova O, Boesen M, Bliddal H et al. Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology. Scandinavian Journal of Rheumatology. 2012 mar;41(2):89-94. Tilgængelig fra: 10.3109/03009742.2011.608375 Alcalde M, D'Agostino MA, Bruyn GAW, Möller I, Iagnocco A, Wakefield RJ et al. A systematic literature review of US definitions, scoring systems and validity according to the OMERACT filter for tendon lesion in RA and other inflammatory joint diseases. Rheumatology (Oxford, England). 2012;51(7):1246-60. Tilgængelig fra: 10.1093/rheumatology/kes018

Boesen M, Kubassova O, Bouert R, Axelsen MB, Østergaard M, Cimmino MA et al. Correlation between computer-aided dynamic gadolinium-enhanced MRI assessment of inflammation and semi-quantitative synovitis and bone marrow oedema scores of the wrist in patients with rheumatoid arthritis--a cohort study. Rheumatology. 2012;51(1):134-43. Tilgængelig fra: 10.1093/rheumatology/ker220 Boesen M, Ellegaard K, Boesen L, Cimmino MA, Jensen PS, Terslev L et al. Ultrasound Doppler Score Correlates with OMERACT RAMRIS Bone Marrow Oedema and Synovitis Score in the Wrist Joint of Patients with Rheumatoid Arthritis. Ultraschall in der Medizin. 2012;33(7):E166-E172. Tilgængelig fra: 10.1055/s-0029-1245922 Bruyn GAW, Möller I, Garrido J, Bong D, d'agostino M-A, Iagnocco A et al. Reliability testing of tendon disease using two different scanning methods in patients with rheumatoid arthritis. Rheumatology (Oxford, England). 2012;51(9):1655-61. Tilgængelig fra: 10.1093/rheumatology/kes103 Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U et al. Effectiveness of diseasemodifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration. Annals of the Rheumatic Diseases. 2012;71(3):374-377. Tilgængelig fra: 10.1136/annrheumdis-2011-200003 Ellingsen TJ, Hansen I, Thorsen J, Kuno Møller B, Tarp U, Jacobsen S et al. Up-regulated dipeptidylpeptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis. Clinical and Experimental Rheumatology. 2012;30(1):58-63. Hammer HB, Terslev L. Role of ultrasound in managing rheumatoid arthritis. Current Rheumatology Reports (Online). 2012;14(5):438-44. Tilgængelig fra: 10.1007/s11926-012-0266-2 Hermann K-GA, Baraliakos X, van der Heijde DMFM, Jurik A-G, Landewé R, Marzo-Ortega H et al. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Annals of the Rheumatic Diseases. 2012;71(8):1278-88. Tilgængelig fra: 10.1136/ard.2011.150680 Hetland ML, Jensen DV, Tarp U. DANBIO: Dansk Reumatologisk Database. Ugeskrift for Laeger. 2012;174(42):2520. Hetland ML, Østergaard M, Ejbjerg B, Jacobsen S, Stengaard-Pedersen K, Junker P et al. Short- and longterm efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-ccp, IgM-RF and CRP. Annals of the Rheumatic Diseases. 2012;71:851-6. Tilgængelig fra: 10.1136/annrheumdis-2011-200632

Hetland ML, Hørslev-Petersen K. The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis. Clinical and Experimental Rheumatology. 2012;30(4 Suppl 73):S44-9. Jawaheer D, Olsen J, Hetland ML. Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -- results from the DANBIO registry. Journal of Rheumatology. 2012;39(1):46-53. Tilgængelig fra: 10.3899/jrheum.110548 Kaeley GS, D'Agostino MA, Grassi W, Østergaard M, Olivieri I. GRAPPA 2011: proceedings from the ultrasound imaging module. Journal of Rheumatology. 2012;39(11):2211-3. Tilgængelig fra: 10.3899/jrheum.120826 Khan NA, Spencer HJ, Abda EA, Alten R, Pohl C, Ancuta C et al. Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?. Annals of the Rheumatic Diseases. 2012;71(12):1942-9. Tilgængelig fra: 10.1136/annrheumdis- 2011-201142 Krintel SB, Palermo G, Johansen JS, Germer S, Essioux L, Benayed R et al. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis. Pharmacogenetics and Genomics. 2012;22(8):577-89. Tilgængelig fra: 10.1097/FPC.0b013e3283544043 Lassen IN, Dahlerup JF, Belard E, Gerstoft J, Kjeldsen JCW, Kragballe K et al. Guidelines for screening, prophylaxis and critical information prior to initiating anti-tnf-alpha treatment. Danish Medical Journal. 2012;59(7):C4480. Laurberg TB, Ellingsen TJ, Thorsen J, Møller BK, Hansen IT, Tarp U et al. Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment. Rheumatology International. 2012;32(2):501-4. Tilgængelig fra: 10.1007/s00296-010-1683-z Mandl P, Naredo E, Conaghan PG, D'Agostino M-A, Wakefield RJ, Bachta A et al. Practice of ultrasoundguided arthrocentesis and joint injection, including training and implementation, in Europe: results of a survey of experts and scientific societies. Rheumatology. 2012;51(1):184-90. Tilgængelig fra: 10.1093/rheumatology/ker331 Mandl P, Brossard M, Aegerter P, Backhaus M, Bruyn GA, Chary-Valckenaere I et al. Ultrasound evaluation of fluid in knee recesses at varying degrees of flexion. Arthritis Care & Research. 2012;64(5):773-9. Tilgængelig fra: 10.1002/acr.21598

McQueen FM, Østergaard M. Imaging in rheumatology: new tools for use in clinical practice in 2012. Preface. Best Practice & Research: Clinical Rheumatology. 2012;26(6):743-9. Tilgængelig fra: 10.1016/j.berh.2012.10.001 Pedersen SJ, Weber U, Østergaard M. The diagnostic utility of MRI in spondyloarthritis. Best Practice & Research: Clinical Rheumatology. 2012;26(6):751-66. Tilgængelig fra: 10.1016/j.berh.2012.10.005 Szkudlarek M, Wakefield RJ, Backhaus M, Terslev L. The discriminatory capacity of ultrasound in rheumatoid arthritis: active vs inactive, early vs advanced, and more. Rheumatology (Oxford, England). 2012;51 Suppl 7:vii6-9. Tilgængelig fra: 10.1093/rheumatology/kes334 Sørensen J, Linde L, Østergaard M, Hetland ML. Quality-Adjusted Life Expectancies in Patients with Rheumatoid Arthritis-Comparison of Index Scores from EQ-5D, 15D, and SF-6D. Value in Health. 2012;15(2):334-9. Tilgængelig fra: 10.1016/j.jval.2011.09.010 Tan YK, Østergaard M, Conaghan PG. Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imaging. Rheumatology (Oxford, England). 2012;51 Suppl 7:vii36-42. Tilgængelig fra: 10.1093/rheumatology/kes329 Terslev L, Ellegaard K, Christensen R, Szkudlarek M, Schmidt WA, Jensen PS et al. Head-to-head comparison of quantitative and semi-quantitative ultrasound scoring systems for rheumatoid arthritis: reliability, agreement and construct validity. Rheumatology. 2012;51(11):2034-8. Tilgængelig fra: 10.1093/rheumatology/kes124 Terslev L, D'Agostino MA, Brossard M, Aegerter P, Balint P, Backhaus M et al. Which Knee and Probe Position Determines the Final Diagnosis of Knee Inflammation by Ultrasound?: Results from a European Multicenter Study. Ultraschall in der Medizin. 2012;E173-8. Tilgængelig fra: 10.1055/s-0031-1299322 Weber U, Pedersen SJ, Østergaard M, Rufibach K, Lambert RG, Maksymowych WP. Can erosions on MRI of the sacroiliac joints be reliably detected in patients with ankylosing spondylitis? - A cross-sectional study. Arthritis Research & Therapy. 2012;14(3):R124. Tilgængelig fra: 10.1186/ar3854 Østergaard M. Can imaging be used for inflammatory arthritis screening?. Seminars in Musculoskeletal Radiology. 2012;16(5):401-9. Tilgængelig fra: 10.1055/s-0032-1329893 Østergaard M, Lambert RGW. Imaging in ankylosing spondylitis. Therapeutic Advances in Musculoskeletal Disease. 2012;4(4):301-11. Tilgængelig fra: 10.1177/1759720X11436240

Østergaard M, Poggenborg RP. Magnetic resonance imaging in psoriatic arthritis -- update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting. Journal of Rheumatology. 2012;39(2):408-12. Tilgængelig fra: 10.3899/jrheum.111235 Duer-Jensen A, Hetland ML, Hørslev-Petersen K, L B, Ejbjerg BJ, Hansen MS et al. Reply to comment by van der Helm - van Mil et al. "The additive value of magnetic resonance imaging for bone edema in predicting rheumatoid arthritis development in early undiffentiated arthritis". Arthritis & Rheumatism. 2012;64:322-3. Wakefield RJ, D'Agostino MA, Naredo E, Buch MH, Iagnocco A, Terslev L et al. After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?. Postgraduate Medical Journal. 2012;88(1042):482-6. Tilgængelig fra: 10.1136/postgradmedj-2011-201048rep Wakefield RJ, D'Agostino MA, Naredo E, Buch MH, Iagnocco A, Terslev L et al. After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?. Annals of the Rheumatic Diseases. 2012;71(6):799-803. Tilgængelig fra: 10.1136/annrheumdis-2011-201048 Hetland ML, Jensen DV. DANBIO Årsrapport 2011. GP-Tryk A/S, 2012. 106 s. Stengaard-Pedersen K, Østergaard M, Hørslev-Petersen K, Hetland ML. Reumatoid artrit. I Reumatologi. 3 udg. FADL's Forlag. 2012. Sørensen IJ. Reumatologiske manifestationer ved medicinske sygdomme. I Reumatologi. FADL's Forlag. 2012. Sørensen IJ. Spondylitis ankylopoietica. I Reumatologi. FADL's Forlag. 2012. Østergaard M, Lambert RL, Grassi W. Imaging modalities in rheumatic diseases. I Kelley s Textbook of Rheumatology. 2012. Krintel SB, Essioux L, Wool A, Johansen JS, Schreiber E, Zekharya T et al CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis [Online] 2012 [Citeret 2012 jan 01] Tilgængelig fra: 10.1371/journal.pone.0038539 Poggenborg RP. Psoriasisartrit - moderne billedmetoder. 2 s. 2012. (BestPractice). Slot O, Hindrup JS. Krystalartritter. I Reumatologi. FADL's Forlag. 2012. s. 223-36.

2011 Hetland ML, Jacobsen S, Manniche C, Tarp U. Behandlingsstrategi, hjerte-kar-sygdom og databaser. Ugeskrift for laeger. 2011 mar 7;173(10):715. Hazlewood G, Aletaha D, Carmona L, Landewé RBM, van der Heijde DM, Bijlsma JWJ et al. Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. Journal of Rheumatology. 2011 mar 1;87:54-8. Tilgængelig fra: 10.3899/jrheum.101076 Døhn UM, Ejbjerg B, Boonen A, Hetland ML, Hansen MS, Knudsen LS et al. No overall progression and occasional repair of erosions despite persistent inflammation in adalimumab-treated rheumatoid arthritis patients: results from a longitudinal comparative MRI, ultrasonography, CT and radiography study. Annals of the Rheumatic Diseases. 2011 feb 1;70(2):252-8. Tilgængelig fra: 10.1136/ard.2009.123729 Glintborg B, Østergaard M, Dreyer L, Krogh NS, Tarp U, Hansen MS et al. Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis & Rheumatism. 2011 feb 1;63(2):382-90. Tilgængelig fra: 10.1002/art.30117 Gossec L, Bijlsma JWJ, Bombardier C, Canhão H, Devlin J, Edwards LC et al. Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists. Annals of the Rheumatic Diseases. 2011 feb 1;70(2):388-9. Tilgængelig fra: 10.1136/ard.2010.128652 Bøyesen P, Haavardsholm EA, van der Heijde D, Østergaard M, Hammer HB, Sesseng S et al. Prediction of MRI erosive progression: a comparison of modern imaging modalities in early rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 2011 jan 1;70(1):176-9. Tilgængelig fra: 10.1136/ard.2009.126953 Machado P, Castrejon I, Katchamart W, Koevoets R, Kuriya B, Schoels M et al. Multinational evidencebased recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 2011 jan;70(1):15-24. Tilgængelig fra: 10.1136/ard.2010.130625 Rudwaleit M, van der Heijde D, Landewé R, Akkoc N, Brandt J, Chou CT et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Annals of the Rheumatic Diseases. 2011 jan;70(1):25-31. Tilgængelig fra: 10.1136/ard.2010.133645

Bélard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK et al. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflammatory bowel diseases. 2011;17(11):2340-2349. Tilgængelig fra: 10.1002/ibd.21605 Boesen M, Kubassova O, Cimmino MA, Østergaard M, Taylor P, Danneskiold-Samsoe B et al. Dynamic Contrast Enhanced MRI Can Monitor the Very Early Inflammatory Treatment Response upon Intra-Articular Steroid Injection in the Knee Joint: A Case Report with Review of the Literature. Arthritis News. 2011;2011(Article ID 578252). Tilgængelig fra: 10.1155/2011/578252 Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T et al. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2011;70(6):909-20. Tilgængelig fra: 10.1136/ard.2010.144998 Bøyesen P, Haavardsholm EA, Østergaard M, van der Heijde D, Sesseng S, Kvien TK. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression. Annals of the Rheumatic Diseases. 2011;70(3):428-33. Tilgængelig fra: 10.1136/ard.2009.123950 Bøyesen P, McQueen FM, Gandjbakhch F, Lillegraven S, Coates L, Wiell C et al. The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop. Journal of Rheumatology. 2011;38(9):2034-8. Tilgængelig fra: 10.3899/jrheum.110420 Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U et al. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Annals of the Rheumatic Diseases. 2011;70(9):1575-1580. Tilgængelig fra: 10.1136/ard.2010.148759 Christensen AF, Lindegaard H, Hørslev-Petersen K, Hetland ML, Ejbjerg BJ, Stengaard-Pedersen K et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-ccp)-positive versus anti-ccp-negative early rheumatoid arthritis. Journal of Rheumatology. 2011;38(8):1563-8. Tilgængelig fra: 10.3899/jrheum.101241 Cohen SB, Potter H, Deodhar A, Emery P, Conaghan P, Østergaard M. Extremity magnetic resonance imaging in rheumatoid arthritis: Updated literature review. Arthritis Care & Research. 2011;63(5):660-665. Tilgængelig fra: 10.1002/acr.20413

Conaghan PG, Emery P, Østergaard M, Keystone EC, Genovese MC, Hsia EC et al. Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial. Annals of the Rheumatic Diseases. 2011;70(11):1968-74. Tilgængelig fra: 10.1136/ard.2010.146068 Conaghan PG, McQueen FM, Bird P, Peterfy CG, Haavardsholm EA, Gandjbakhch F et al. Update on research and future directions of the OMERACT MRI inflammatory arthritis group. Journal of Rheumatology. 2011;38(9):2031-3. Tilgængelig fra: 10.3899/jrheum.110419 Duer-Jensen A, Hørslev-Petersen K, Hetland ML, Bak L, Ejbjerg BJ, Hansen MS et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis & Rheumatism. 2011;63(8):2192-202. Tilgængelig fra: 10.1002/art.30396 Ellegaard K, Christensen R, Torp-Pedersen S, Terslev L, Holm CC, Kønig MJ et al. Ultrasound Doppler measurements predict success of treatment with anti-tnf-α drug in patients with rheumatoid arthritis: a prospective cohort study. Rheumatology. 2011;50(3):506-12. Tilgængelig fra: 10.1093/rheumatology/keq336 Emery P, van der Heijde D, Østergaard M, Conaghan PG, Genovese MC, Keystone EC et al. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2011;70(12):2126-30. Tilgængelig fra: 10.1136/ard.2011.154500 Gandjbakhch F, Conaghan PG, Ejbjerg B, Haavardsholm EA, Foltz V, Brown AK et al. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. Journal of Rheumatology. 2011;38(9):2039-44. Tilgængelig fra: 10.3899/jrheum.110421 Gandjbakhch F, Terslev L, Joshua F, Wakefield RJ, Naredo E, D'Agostino MA et al. Ultrasound in the evaluation of enthesitis: status and perspectives. Arthritis Research & Therapy. 2011;13(6):R188. Tilgængelig fra: 10.1186/ar3516 Greisen SR, Moller HJ, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Jørgensen A et al. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Clinical and Experimental Rheumatology. 2011;29(4):689-92. Hetland ML. DANBIO-powerful research database and electronic patient record. Rheumatology. 2011;50(1):69-77. Tilgængelig fra: 10.1093/rheumatology/keq309

Jacobsson LTH, Hetland ML. New remission criteria for RA: 'modern times' in rheumatology--not a silent film, rather a 3D movie. Annals of the Rheumatic Diseases. 2011;70(3):401-3. Tilgængelig fra: 10.1136/ard.2010.145607 Jørgensen I, Kos J, Krašovec M, Troelsen L, Klarlund M, Jensen TW et al. Serum cysteine proteases and their inhibitors in rheumatoid arthritis: relation to disease activity and radiographic progression. Clinical Rheumatology. 2011;30(5):633-638. Tilgængelig fra: 10.1007/s10067-010-1585-1 Leffers HC, Østergaard M, Glintborg B, Krogh NS, Henriksen HF, Tarp U et al. Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry. Annals of the Rheumatic Diseases. 2011;70(7):1216-22. Tilgængelig fra: 10.1136/ard.2010.140129 Lillegraven S, Bøyesen P, Hammer HB, Østergaard M, Uhlig T, Sesseng S et al. Tenosynovitis of the extensor carpi ulnaris tendon predicts erosive progression in early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2011;70(11):2049-50. Tilgængelig fra: 10.1136/ard.2011.151316 Mandl P, Naredo E, Wakefield RJ, Conaghan PG, D'Agostino MA, OMERACT Ultrasound Task Force et al. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. Journal of Rheumatology. 2011;38(9):2055-62. Tilgængelig fra: 10.3899/jrheum.110424 Naredo E, Wakefield RJ, Iagnocco A, Terslev L, Filippucci E, Gandjbakhch F et al. The OMERACT ultrasound task force--status and perspectives. Journal of Rheumatology. 2011;38(9):2063-7. Tilgængelig fra: 10.3899/jrheum.110425 Nielsen KR, Steffensen RN, Boegsted M, Baech J, Lundbye-Christensen S, Hetland ML et al. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Arthritis Research & Therapy. 2011;13(3):R109. Tilgængelig fra: 10.1186/ar3391 Pedersen SJ, Sørensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N et al. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. Annals of the Rheumatic Diseases. 2011;70(8):1375-81. Tilgζngelig fra: 10.1136/ard.2010.138883

Pedersen SJ, Sørensen IJ, Lambert RGW, Hermann K-GA, Garnero P, Johansen JS et al. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis & Rheumatism. 2011;63(12):3789-800. Tilgængelig fra: 10.1002/art.30627 Pedersen SJ, Chiowchanwisawakit P, Lambert RGW, Østergaard M, Maksymowych WP. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. Journal of Rheumatology. 2011;38(7):1349-54. Tilgængelig fra: 10.3899/jrheum.100925 Poggenborg RP, Terslev L, Pedersen SJ, Østergaard M. Recent advances in imaging in psoriatic arthritis. Therapeutic Advances in Musculoskeletal Disease. 2011;3((1)):43-53. Tilgængelig fra: DOI: 10.1177/1759720X10394031 Spannow AH, Stenboeg E, Jensen MP, Fiirgaard B, Haislund M, Østergaard M et al. Ultrasound and MRI measurements of joint cartilage in healthy children. A validation study. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2011;32 Suppl 1:S110-6. Tilgængelig fra: 10.1055/s-0029-1245374 Strand V, Kingsbury SR, Woodworth T, Landewé R, Østergaard M, Peterfy C et al. OMERACT 10 sharp symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritis. Journal of Rheumatology. 2011;38(9):2009-2013. Tilgængelig fra: 10.3899/jrheum.110415 Sørensen IJ. Spondyloartritis. Månedsskrift for Almen Praksis. 2011;Årgang 89(8):652-663. Terslev L, D'Agostino MA. How to validate the use of musculoskeletal ultrasound in rheumatology for clinical trials. Current Rheumatology Reviews. 2011;7(3):183-186. Tilgængelig fra: DOI: http://dx.doi.org/10.2174/157339711796320574 Weber U, Østergaard M, Lambert RGW, Maksymowych WP. The impact of MRI on the clinical management of inflammatory arthritides. Skeletal Radiology. 2011;40(9):1153-73. Tilgængelig fra: 10.1007/s00256-011-1204-5 Østergaard M, Bøyesen P, Eshed I, Gandjbakhch F, Lillegraven S, Bird P et al. Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring system. Journal of Rheumatology. 2011;38(9):2045-50. Tilgængelig fra: 10.3899/jrheum.110422

Østergaard M, Møller Døhn U, Duer-Jensen A, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K et al. Patterns of magnetic resonance imaging bone erosion in rheumatoid arthritis--which bones are most frequently involved and show the most change?. Journal of Rheumatology. 2011;38(9):2014-2017. Tilgængelig fra: 10.3899/jrheum.110416 Østergaard M, Emery P, Conaghan PG, Fleischmann R, Hsia EC, Xu W et al. Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients. Arthritis & Rheumatism. 2011;63(12):3712-22. Tilgængelig fra: 10.1002/art.30592 Østergaard M, Baslund B, Rigby W, Rojkovich B, Jorgensen C, Dawes PT et al. Reply to "Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al". Arthritis & Rheumatism. 2011;63(1):305. Tilgængelig fra: 10.1002/art.30097 Hetland ML, Hansen A. DANBIO Årsrapport 2010. Eget Forlag, 2011. Hetland ML. Modern treatment strategies in rheumatoid arthritis: Impact on, and predictors of, disease activity and disease course. Danish Medical Bulletin, 2011. 84 s. Pedersen SJ, Østergaard M, Wakefield R IMAGING [Online] 2011 [Citeret 2011 jan 01] Tilgængelig fra: URL:http://www.eular-onlinecourse.com 2010 Naredo E, D'Agostino MA, Conaghan PG, Backhaus M, Balint P, Bruyn GAW et al. Current state of musculoskeletal ultrasound training and implementation in Europe: results of a survey of experts and scientific societies. Rheumatology (Oxford, England). 2010 dec 1;49(12):2438-43. Tilgængelig fra: 10.1093/rheumatology/keq243 Weber U, Lambert RGW, Pedersen SJ, Hodler J, Østergaard M, Maksymowych WP. Assessment of structural lesions in sacroiliac joints enhances diagnostic utility of magnetic resonance imaging in early spondylarthritis. Arthritis Care & Research. 2010 dec 1;62(12):1763-71. Tilgængelig fra: 10.1002/acr.20312 Glintborg B, Østergaard M, Krogh NS, Dreyer L, Kristensen HL, Hetland ML. Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry. Annals of the Rheumatic Diseases. 2010 nov 1;69(11):2002-8. Tilgængelig fra: 10.1136/ard.2009.124446

Slot O, Terslev L. Clinical Images: Ultrasonographic signs of gout in symmetric polyarthritis. Arthritis & Rheumatism. 2010 nov 1;62(11):3487. Tilgængelig fra: 10.1002/art.27646 Hetland ML, Stengaard-Pedersen K, Junker MP, Østergaard M, Ejbjerg BJ, Jacobsen S et al. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-ccp predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Annals of the Rheumatic Diseases. 2010 okt 1;69(10):1789-95. Tilgængelig fra: 10.1136/ard.2009.125534 Madsen OR, Faurschou M, Loft AG, Sørensen IJ, Knudsen JB, Baslund B et al. Evidence-based recommendations for treatment with methotrexate in rheumatic disorders. Danish Medical Bulletin (Online). 2010 okt 1;57(10):A4190. Rasmussen TK, Andersen T, Hvid M, Hetland ML, Hørslev-Petersen K, Stengaard-Pedersen K et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. Journal of Rheumatology. 2010 okt 1;37(10):2014-20. Tilgængelig fra: 10.3899/jrheum.100259 Weber U, Lambert RGW, Østergaard M, Hodler J, Pedersen SJ, Maksymowych WP. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis & Rheumatism. 2010 okt 1;62(10):3048-58. Tilgængelig fra: 10.1002/art.27571 Østergaard M, Poggenborg RP, Axelsen MB, Pedersen SJ. Magnetic resonance imaging in spondyloarthritis- -how to quantify findings and measure response. Best Practice & Research: Clinical Rheumatology. 2010 okt 1;24(5):637-57. Tilgængelig fra: 10.1016/j.berh.2010.06.001 Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R et al. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Annals of the Rheumatic Diseases. 2010 sep 1;69(9):1596-602. Tilgængelig fra: 10.1136/ard.2009.125526 Plant D, Flynn E, Mbarek H, Dieudé P, Cornelis F, Arlestig L et al. Investigation of potential non-hla rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Annals of the Rheumatic Diseases. 2010 aug 1;69(8):1548-53. Tilgængelig fra: 10.1136/ard.2009.121020 Østergaard M, Baslund B, Rigby W, Rojkovich B, Jorgensen C, Dawes PT et al. Ofatumumab, a human anti- CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study. Arthritis & Rheumatism. 2010 aug 1;62(8):2227-38. Tilgængelig fra: 10.1002/art.27524

Hetland ML. Danske data dokumenterer forskel i tumornekrosefaktorhaemmeres behandlingseffekt hos patienter med reumatoid artritis. Ugeskrift for laeger. 2010 jun 28;172(26):2003; author reply 2003-4. Pedersen SJ, Sørensen IJ, Hermann K-GA, Madsen OR, Tvede N, Hansen MS et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Annals of the Rheumatic Diseases. 2010 jun 1;69(6):1065-71. Tilgængelig fra: 10.1136/ard.2009.111187 Dougados M, Jousse-Joulin S, Mistretta F, d'agostino M-A, Backhaus M, Bentin J et al. Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2010 maj 1;69(5):828-33. Tilgængelig fra: 10.1136/ard.2009.115493 Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Annals of the Rheumatic Diseases. 2010 apr;69(4):631-7. Tilgængelig fra: 10.1136/ard.2009.123919 Dufour N, Thamsborg G, Oefeldt A, Lundsgaard C, Stender S. Treatment of chronic low back pain: a randomized, clinical trial comparing group-based multidisciplinary biopsychosocial rehabilitation and intensive individual therapist-assisted back muscle strengthening exercises. Spine. 2010 mar 1;35(5):469-76. Tilgængelig fra: 10.1097/BRS.0b013e3181b8db2e Linde L, Sørensen J, Østergaard M, Hørslev-Petersen K, Hetland ML. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?. Journal of Rheumatology. 2010 feb 1;37(2):285-90. Tilgængelig fra: 10.3899/jrheum.090898 Christensen AF, Sørensen GL, Hørslev-Petersen K, Holmskov U, Lindegaard HM, Junker K et al. Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis. Arthritis Research & Therapy. 2010 jan 1;12(2):R39. Tilgængelig fra: 10.1186/ar2948 Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis & Rheumatism. 2010 jan 1;62(1):22-32. Tilgængelig fra: 10.1002/art.27227

Schefte DB, Hetland ML. An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, the Health Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions. Rheumatology (Oxford, England). 2010 jan 1;49(1):99-104. Tilgængelig fra: 10.1093/rheumatology/kep333 Christensen AF, Hørslev-Petersen K, Christgau S, Lindegaard HM, Lottenburger T, Junker K et al. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. Journal of Rheumatology. 2010;37(6):1113-20. Tilgængelig fra: 10.3899/jrheum.091265 Jawaheer D, Olsen J, Lahiff M, Forsberg S, Lähteenmäki J, da Silveira IG et al. Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study. Clinical and Experimental Rheumatology. 2010;28(4):454-61. Naranjo A, Toloza S, Guimaraes da Silveira I, Lazovskis J, Hetland ML, Hamoud H et al. Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database. Clinical and Experimental Rheumatology. 2010;28(6):820-7. Pedersen SJ, Hetland ML, Sørensen IJ, Østergaard M, Nielsen HJ, Johansen JS. Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNF alpha inhibitors. Clinical Rheumatology. 2010;29(11):1301-1309. Pedersen SJ, Hetland ML, Sørensen IJ, Østergaard M, Nielsen HJ, Johansen JS. Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors. Clinical Rheumatology. 2010;29(11):1301-9. Tilgængelig fra: 10.1007/s10067-010-1528-x Søgaard R, Sørensen J, Linde L, Hetland ML. The significance of presenteeism for the value of lost production. The case of rheumatoid arthritis. ClinicoEconomics and Outcomes Research. 2010. Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis. Reply to comment by Francis and Block (letter). Arthritis & Rheumatism. 2010. Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al. Differences in the efficacy of TNF-inhibitors are supported by sensitivity analyses (letter). Arthritis & Rheumatism. 2010. Tilgængelig fra: http://dx.doi.org/10.1002/art.27609

Hansen A, Hetland ML. DANBIO årsrapport 2009. 2010. Duer-Jensen A. Magnetic resonance imaging in early undifferentiated arthritis and rheumatoid arthritis. University of Copenhagen, 2010. Pedersen SJ. Biomarkers of inflammation, angiogenesis and cartilage and bone turnover in patients with axial spondyloarthritis relation with disease activity, treatment response and radiographic progression. University of Copenhagen, 2010. Sokka T, Kautiainen H, Pincus T, Verstappen SMM, Aggarwal A, Alten R et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. I Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.. 2010. s. R42. Tilgængelig fra: 10.1186/ar2951 Terslev L. Pitfalls in Doppler Ultrasound. I Essential Applications of Musculoskeletal Ultrasound in Rheumatology. W. B. Saunders Company. 2010. Terslev L. Synovitis. I Essential Applications of Musculoskeletal Ultrasound in Rheumatology. W. B. Saunders Company. 2010. Østergaard M Clarification of the role of ultrasonography, magnetic resonance imaging and conventional radiography in the ACR/EULAR 2010 rheumatoid classification criteria - comment to the article by Aletaha et al. [Online] 2010 [Citeret 2010 jan 01] Szkudlarek M. Rheumatoid arthritis. I Wakefield RJ, D'Agostino MA, red., Essential Applications of Musculoskeletal Ultrasound in Rheumatology. W. B. Saunders Company. 2010. Sørensen IJ, Ejstrup L. Spondylartropatier. I Freisleben S, red., Immuninflammatoriske Sygdomme. Baggrund og biologiske lægemidler. 1. udg. FADL's Forlag. 2010. s. 145-162. 2009 Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Annals of the Rheumatic Diseases. 2009 nov;68(11):1666-72. Tilgængelig fra: 10.1136/ard.2009.109983

Haavardsholm EA, Østergaard M, Hammer HB, Bøyesen P, Boonen A, van der Heijde D et al. Monitoring anti-tnfalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage. Annals of the Rheumatic Diseases. 2009 okt;68(10):1572-9. Tilgængelig fra: 10.1136/ard.2008.091801 Møller Døhn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A et al. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Annals of the Rheumatic Diseases. 2009 okt;68(10):1585-90. Tilgængelig fra: 10.1136/ard.2008.097048 Laurberg TB, Frystyk J, Ellingsen T, Hansen IT, Jørgensen A, Tarp U et al. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. Journal of Rheumatology. 2009 sep;36(9):1885-91. Tilgængelig fra: 10.3899/jrheum.080907 Duer-Jensen A, Ejbjerg B, Albrecht-Beste E, Vestergaard A, Døhn UM, Hetland ML et al. Does low-field dedicated extremity MRI (E-MRI) reliably detect bone erosions in rheumatoid arthritis?: A comparison of two different E-MRI units and conventional radiography with high-resolution CT scanning. Annals of the Rheumatic Diseases. 2009 aug;68(8):1296-302. Tilgængelig fra: 10.1136/ard.2008.093591 Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Østergaard M et al. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design. Journal of Rheumatology. 2009 aug;36(8):1792-9. Tilgængelig fra: 10.3899/jrheum090347 Maksymowych WP, Landewé R, Tak P-P, Ritchlin CJ, Østergaard M, Mease PJ et al. Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria. Journal of Rheumatology. 2009 aug;36(8):1785-91. Tilgængelig fra: 10.3899/jrheum.090346 Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J et al. Multinational evidencebased recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases. 2009 jul;68(7):1086-93. Tilgængelig fra: 10.1136/ard.2008.094474